Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vivekananda Sarangi

Showing results (1-10 of 38) with videos related to

Pageof 4
Sort By:
BMC Bioinformatics|November 13, 2020
SCELLECTOR: ranking amplification bias in single cells using shallow sequencingVivekananda Sarangi, Alexandre Jourdon, Taejeong Bae, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|March 4, 2021
<i>SLCO1B1</i>: Application and Limitations of Deep Mutational Scanning for Genomic Missense Variant FunctionLingxin Zhang, Vivekananda Sarangi, Ming-Fen Ho, et al.
Plos One|December 21, 2013
SoftSearch: integration of multiple sequence features to identify breakpoints of structural variationsSteven N Hart, Vivekananda Sarangi, Raymond Moore, et al.
Expert Systems with Applications|August 27, 2025
Corrigendum to "Identification of gene regulatory networks associated with breast cancer patient survival using an interpretable deep neural network model" [Expert Syst. Appl. 262 (2025) 125632]Xue Wang, Vivekananda Sarangi, Daniel P Wickland, et al.
Expert Systems with Applications|December 16, 2024
Identification of Gene Regulatory Networks Associated with Breast Cancer Patient Survival Using an Interpretable Deep Neural Network ModelXue Wang, Vivekananda Sarangi, Daniel P Wickland, et al.
Plos Computational Biology|April 20, 2022
All2: A tool for selecting mosaic mutations from comprehensive multi-cell comparisonsVivekananda Sarangi, Yeongjun Jang, Milovan Suvakov, et al.
Plos Computational Biology|November 15, 2022
Correction: All2: A tool for selecting mosaic mutations from comprehensive multi-cell comparisonsVivekananda Sarangi, Yeongjun Jang, Milovan Suvakov, et al.
BMC Medical Genomics|June 23, 2021
Frequent POLE-driven hypermutation in ovarian endometrioid cancer revealed by mutational signatures in RNA sequencingJaime I Davila, Pritha Chanana, Vivekananda Sarangi, et al.
Clinical and Translational Science|February 1, 2020
CYP2C9 and CYP2C19: Deep Mutational Scanning and Functional Characterization of Genomic Missense VariantsLingxin Zhang, Vivekananda Sarangi, Irene Moon, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|September 3, 2025
HNF1A-inactived Hepatocellular Adenomas in Fibropolycystic Kidney and Liver Disease Are Associated with Germline HNF1B VariantCatherine E Hagen, Dipti M Karamchandani, Luisa Ricaurte, et al.
Pageof 4

Showing results (1-10 of 38) with videos related to

Sort By:
Pageof 4
BMC Bioinformatics|November 13, 2020
SCELLECTOR: ranking amplification bias in single cells using shallow sequencingVivekananda Sarangi, Alexandre Jourdon, Taejeong Bae, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|March 4, 2021
<i>SLCO1B1</i>: Application and Limitations of Deep Mutational Scanning for Genomic Missense Variant FunctionLingxin Zhang, Vivekananda Sarangi, Ming-Fen Ho, et al.
Plos One|December 21, 2013
SoftSearch: integration of multiple sequence features to identify breakpoints of structural variationsSteven N Hart, Vivekananda Sarangi, Raymond Moore, et al.
Expert Systems with Applications|August 27, 2025
Corrigendum to "Identification of gene regulatory networks associated with breast cancer patient survival using an interpretable deep neural network model" [Expert Syst. Appl. 262 (2025) 125632]Xue Wang, Vivekananda Sarangi, Daniel P Wickland, et al.
Expert Systems with Applications|December 16, 2024
Identification of Gene Regulatory Networks Associated with Breast Cancer Patient Survival Using an Interpretable Deep Neural Network ModelXue Wang, Vivekananda Sarangi, Daniel P Wickland, et al.
Plos Computational Biology|April 20, 2022
All2: A tool for selecting mosaic mutations from comprehensive multi-cell comparisonsVivekananda Sarangi, Yeongjun Jang, Milovan Suvakov, et al.
Plos Computational Biology|November 15, 2022
Correction: All2: A tool for selecting mosaic mutations from comprehensive multi-cell comparisonsVivekananda Sarangi, Yeongjun Jang, Milovan Suvakov, et al.
BMC Medical Genomics|June 23, 2021
Frequent POLE-driven hypermutation in ovarian endometrioid cancer revealed by mutational signatures in RNA sequencingJaime I Davila, Pritha Chanana, Vivekananda Sarangi, et al.
Clinical and Translational Science|February 1, 2020
CYP2C9 and CYP2C19: Deep Mutational Scanning and Functional Characterization of Genomic Missense VariantsLingxin Zhang, Vivekananda Sarangi, Irene Moon, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|September 3, 2025
HNF1A-inactived Hepatocellular Adenomas in Fibropolycystic Kidney and Liver Disease Are Associated with Germline HNF1B VariantCatherine E Hagen, Dipti M Karamchandani, Luisa Ricaurte, et al.
Pageof 4